Source: https://www.federalregister.gov/documents/2014/01/16/2014-00721/withdrawal-of-approval-of-new-animal-drug-applications-argent-laboratories-formalin-tricaine
Timestamp: 2017-08-17 22:27:52
Document Index: 427580065

Matched Legal Cases: ['arts 510', '§\u2009510', 'art 529', '§\u2009529', '§\u2009529', '§\u2009510', '§\u2009529', '§\u2009529', '§\u2009510']

Federal Register :: Withdrawal of Approval of New Animal Drug Applications; Argent Laboratories; Formalin; Tricaine Methanesulfonate
Withdrawal of Approval of New Animal Drug Applications; Argent Laboratories; Formalin; Tricaine Methanesulfonate
A Rule by the Food and Drug Administration on 01/16/2014
This final rule is effective January 27, 2014.
79 FR 2785
2785-2786 (2 pages)
2014-00721
https://www.federalregister.gov/d/2014-00721 https://www.federalregister.gov/d/2014-00721
The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect the withdrawal of approval of two new animal drug applications (NADAs) held by Argent Laboratories. Withdrawal of approval of these NADAs was at the sponsor's request because the products are no longer manufactured or marketed.
David Alterman, Center for Veterinary Medicine (HFV-212), Food and Drug Administration, 7519 Standish Pl., Rockville, MD 20855, 240-453-6843 david.alterman@fda.hhs.gov.
Argent Laboratories, 8702 152d Ave. NE., Redmond, WA 98052 has requested that FDA withdraw approval of the following two NADAs because the products are no longer manufactured or marketed: NADA 042-427 for FINQUEL (tricaine methanesulfonate) and NADA 140-831 for PARACIDE-F (formalin).
Elsewhere in this issue of the Federal Register, FDA gave notice that approval of NADAs 042-427 and 140-831, and all supplements and amendments thereto, is withdrawn. As provided in the regulatory text of this document, the Start Printed Page 2786animal drug regulations are amended to reflect these voluntary withdrawals of approval.
Following these withdrawals of approval, Argent Laboratories will no longer be the sponsor of an approved application. Accordingly, 21 CFR 510.600(c) is being amended to remove the entries for this firm.
Therefore, under the Federal Food, Drug, and Cosmetic Act and under the authority delegated to the Commissioner of Food and Drugs and redelegated to the Center for Veterinary Medicine, 21 CFR parts 510 and 529 are amended as follows:
2. In § 510.600, in the table in paragraph (c)(1), remove the entry for “Argent Laboratories”; and in the table in paragraph (c)(2), remove the entry for “051212”.
3. The authority citation for 21 CFR part 529 continues to read as follows:
4. In § 529.1030:
b. Remove paragraphs (d)(1)(i) and (d)(1)(ii), and redesignate paragraphs (d)(1)(iii), (d)(1)(iv), and (d)(1)(v) as paragraphs (d)(1)(i), (d)(1)(ii), and (d)(1)(iii);
c. Remove paragraphs (d)(2)(i) and (d)(2)(ii), and redesignate paragraphs (d)(2)(iii), (d)(2)(iv), and (d)(2)(v) as paragraphs (d)(2)(i), (d)(2)(ii), and (d)(2)(iii); and
d. Revise the introductory text in newly designated paragraph (d)(2)(ii), and revise paragraph (d)(2)(iii).
§ 529.1030
(b) Sponsors. See Nos. 049968, 050378, and 067188 in § 510.600(c) of this chapter.
(ii) For control of external parasites on finfish:
(iii) For control of fungi of the family Saprolegniaceae on finfish eggs: Eggs of all finfish except Acipenseriformes, 1,000 to 2,000 µL/L (ppm) for 15 minutes; eggs of Acipenseriformes, up to 1,500 μL/L (ppm) for 15 minutes.
5. Revise § 529.2503 to read as follows:
§ 529.2503
Tricaine methanesulfonate.
(a) Specifications. Ethyl-m-amino-benzoate methanesulfonate.
(b) Sponsor. See No. 050378 in § 510.600(c) of this chapter.
(1) Amount— (i) For fish the drug is added to ambient water at a concentration of from 15 to 330 milligrams per liter depending upon the degree of anesthetization or sedation desired, the species and size of the fish, and the temperature and softness of the water. Preliminary tests of solutions must be made with small numbers of fish to determine the desired rates of sedation or anesthesia and the appropriate exposure times for the specific lots of fish under prevailing conditions.
(ii) For amphibians and other aquatic coldblooded animals, the drug is added to ambient water in concentrations of from 1:1000 to 1:20,000 depending upon species and stage of development.
(2) Indications for use. It is used for the temporary immobilization of fish, amphibians, and other aquatic coldblooded animals (poikilotherms) as an aid in handling during manual spawning (fish stripping), weighing, measuring, marking, surgical operations, transport, photography, and research.
(3) Limitations. Do not use within 21 days of harvesting fish for food. Use in fish intended for food should be restricted to Ictaluridae, Salmonidae, Esocidae, and Percidae, and water temperature should exceed 10 °C. (50 °F). In other fish and in cold-blooded animals, the drug should be limited to hatchery or laboratory use.
[FR Doc. 2014-00721 Filed 1-15-14; 8:45 am]